Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore various ways to get quick cash today. These strategies will help you access funds when you need them most.
23,336 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Evercore ISI launches SpaceX coverage with an Outperform rating and a $230 target, fueling a new wall street spacex b...
Netflix revealed it used AI to speed production on a documentary, delivering 17 minutes of AI-enhanced footage at hal...
When memory stocks spark market optimism, chipmakers can drive broader gains. This piece breaks down what’s behind th...
A value-factor ETF has surged past the S&P 500 through February 2026, signaling a shift toward fundamentals amid vola...
A new private space station race is heating up, and Vast is stepping in with a bold plan. This could shift how invest...
Microsoft sits near a long-running price anchor as investors weigh AI incentives against macro risks. A decisive move...
A Reddit user with a $3 million portfolio sees a sharp decline to $2.7 million amid tariff chatter and volatility, pr...
Terawulf reports a Q4 revenue miss while its high-performance computing leases rise, signaling a strategic pivot towa...
XRPL adoption is expanding with tokenized funds and stablecoins on the ledger. The focus remains on XRP as it faces b...
A major AI cloud deal sparked a notable move in CoreWeave stock on Wednesday. This article explains what happened, wh...
Bitcoin’s leverage ratio drops on major venues amid rising risk-off mood, as analysts watch whether spot buying retur...